Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-011006

CFO and Treasurer sold 3,035 shares at an average $70.34 ($213,480)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2021-02-11 Sale −2,635 $70.17 $184,908 97,987 D
Krognes Steve E. CFO and Treasurer 2021-02-11 Sale −400 $71.43 $28,571 97,587 D
Open-market sales · 3,035 sh · avg $70.34 · $213,480
Loading xslF345X03/doc4.xml…